Status:
COMPLETED
Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer
Lead Sponsor:
Emory University
Collaborating Sponsors:
National Cancer Institute (NCI)
National Institutes of Health (NIH)
Conditions:
Gastric Carcinoma
Liver and Intrahepatic Bile Duct Carcinoma
Eligibility:
All Genders
Phase:
NA
Brief Summary
This randomized study examines how well zinc works in improving quality of life in patients with gastrointestinal cancer that cannot be removed by surgery who are receiving chemotherapy. Zinc may help...
Detailed Description
PRIMARY OBJECTIVE: I. Assess the effects on quality of life (QOL) when supplementing zinc in upper gastrointestinal (GI) cancer patients while they are receiving chemotherapy. SECONDARY OBJECTIVES: ...
Eligibility Criteria
Inclusion
- Patients who present to adult medical oncology outpatient clinic with new diagnosis of non-resectable gastric, gastro-esophageal, pancreas or biliary cancer
- Patients plan to receive chemotherapy at an Emory Cancer Center
- No prior chemotherapy or radiation therapy for newly diagnosed gastric, gastro-esophageal, pancreas or biliary cancer
- Patients must sign informed consent
Exclusion
- Zinc supplementation is not indicated for pregnant or lactating women therefore, this is an exclusion criteria and women of childbearing age will complete a pregnancy test
Key Trial Info
Start Date :
April 17 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 22 2022
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT03819088
Start Date
April 17 2019
End Date
March 22 2022
Last Update
October 9 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, United States, 30322
2
Emory Saint Joseph's Hospital
Atlanta, Georgia, United States, 30342